Previous studies have consistently reported the correlation between high levels of MDR1 and P-gp with chemotherapy resistance, lymph node metastasis, and reduced survival in patients with cancer [30]. The gene discussed is PGP; the disease is metastatic malignant neoplasm in the lymph nodes.